exact mechanisms are still poorly understood, it is now generally believed that the lack of a conclusive T cell mediated immune response after stimulation with iDC is caused by the absence of inflammatory danger signals in steady-state in vivo conditions and by the low expression levels of costimulatory molecules on iDC [6, 7] . In addition, it has also been demonstrated that iDC actively promote peripheral tolerance by the induction of interleukin (IL)-10-producing immunosuppressive regulatory T cells (Treg) [8] [9] [10] , suggesting the importance of lack of DC maturation for T cell tolerance.
After encounter of a 'danger' signal (e.g. toll-like receptor [TLR] ligand), iDC mature [11] and migrate to the secondary lymphoid organs. Next, upon efficient antigen presentation to T cells, a robust immune response is induced in vivo. This maturation step is believed to be a crucial event to regulate DC function. A growing body of evidence now indicates that traditional DC maturation, as judged by surface marker expression (i.e. the upregulation of antigen-presenting and costimulatory molecules), can no longer be used to distinguish tolerogenic and immunogenic properties of DC. Although mainly iDC seem to trigger IL-10-producing Treg, several reports indicate that mature DC (mDC) are also able to induce IL-10-producing Treg in humans [12, 13] .
In the present study, we examined some of the tolerogenic mechanisms of iDC. We compared the in vitro T cell stimulatory capacity of iDC and mDC in the absence and presence of MHC class Irestricted antigen at the cellular level. Our results indicate that the induction of an inefficient T cell immune response by autologous iDC in vitro (and possibly also in vivo) is not only a passive process (e.g. due to a low expression level of costimulatory molecules), but can also be manipulated in an active manner by the induction of suppressive cytokinesecreting T cells. On the other hand, mDC are capable of overruling T cell immunosuppression despite the co-activation of potential suppressor T cells.
Materials and methods

Dendritic cell culture
Peripheral blood mononuclear cells (PBMC) were obtained from HLA-A*0201-positive human cytomegalovirus (CMV)-seropositive buffy coats provided by the Antwerp Blood 
Flow cytometry
Immunophenotyping of dendritic cells and stimulated T cells was done following previously described procedures [27] . For detection and characterization of expanded antigen-specific T cells, the following tetramers were used for direct immunofluorescence staining: an influenza matrix protein M1-tetramer-PE (a kind gift from Dr Pierre Van der Bruggen, Ludwig Institute for Cancer Research, Université Catholique de Louvain (UCL), Brussels, Belgium) and a CMV pp65-tetramer-PE (Orpegen Pharma, Heidelberg, Germany). For intracellular characterization of stimulated T cells, the following murine anti-human monoclonal antibodies were used for direct immunofluorescence staining: TGF-␤-PE (IQ Products, Groningen, the Netherlands) and IL-10-APC (Becton Dickinson, Erembodegem, Belgium). T cell staining with the anti-TGF-␤ and anti-IL-10 antibodies was done according to the following procedure: 5 x 10 6 T cells were washed and incubated for 16 hrs at 37°C in IMDM supplemented with 5% hAB serum in the presence of 2 µL brefeldin A/10 6 cells/ml (Golgistop, Becton Dickinson). Next, cells were stained for membrane markers (CD3, CD4, CD8 and CD25) for 30 min at 4°C, followed by fixation for 10 min at room temperature with a lyse/fix solution (Becton Dickinson) and permeabilization with Perm2 solution 
Induction of MHC class I-restricted CMV pp65-or influenza M1 peptide-specific T cells
A CMV-specific HLA-A*0201-restricted peptide of the pp65 protein (amino acids (aa) 495-503, NLVPMVATV) and an influenza virus-specific HLA-A*0201-restricted matrix protein M1 peptide (M1; aa 58-66, GILGFVFTL) were used for activation of CMV pp65 and M1 peptide-specific T cells, respectively, as described previously [13] . For T cell activation experiments, PBL were cultured alone or with 5 x 10 5 autologous DC in the presence of CMV pp65 or influenza M1 peptide at a final concentration of 1 µg/ml culture medium. The experiments were performed in 24-well-plates in 2 ml IMDM supplemented with 5% hAB serum. In some experiments, the following neutralizing antibodies were added: 1 µg/ml anti-IL-10 antibody (Sigma) and 1 µg/ml anti-TGF-␤ antibody (R&D, Abingdon, UK). After 7 days of co-culture, T cells were analyzed for antigen specificity by means of tetramer staining and/or by interferon (IFN)-␥ production following antigenic restimulation. 
Suppression assay
Cytokine release assays
Quantitative detection of the cytokine expression profile of iDC and mDC was determined using a human Th1/Th2 multiplex fluorescent bead immunoassay (Bender MedSystems, Vienna, Austria), according to the manufacturer's instructions. For detection of activated IFN-␥-producing CMV pp65 peptide-specific or influenza M1 peptide-specific T cells, cultured PBL were washed and stimulated for 18 hrs at 37°C with 1 µg/ml of CMV pp65 peptide or 1 µg/ml of influenza M1 peptide or left untreated as control. All experiments were done in quadruplicate. Collected supernatant samples were analyzed for secreted IFN-␥ using a commercially available ELISA kit (Human IFN-␥ Cytoset, Biosource, Nivelles, Belgium), according to the manufacturer's instructions.
In some experiments, supernatant samples of DC/T cell co-cultures were analyzed for the presence of The indicated percentages are within the CD3 + CD4 + CD25 -T cell population. The P-values indicated are calculated for CMV pp65 peptide-stimulated PBL versus PBL co-cultured with iDC or mDC in the presence of CMV pp65 peptide.
immunosuppressive cytokines using a human TGF-␤1 ELISA Set (BD Biosciences, San Diego, CA, USA) or an IL-10 EASIA (Biosource, Nivelles, Belgium), according to the manufacturer's instructions. The supernatants of the cultures were not acid-activated before the measurement was performed, in order to measure TGF-␤ in its active form only.
Statistics
The results are expressed as mean Ϯ standard deviation.
Comparisons were validated using paired Student's t-test. A P-value of Յ 0.05 was considered as statistically significant.
Results
Characterization of monocyte-derived immature and mature dendritic cells
We cultured and characterized iDC and mDC as described previously [14, 15] with minor modifications. In order to address the functionality of DC, allogeneic T cell stimulatory capacity of both DC populations was assessed (Fig. 1A) . Therefore, we co-cultured peripheral blood lymphocytes (PBL) with allogeneic iDC or mDC at a 4:1 ratio and used the level of interferon (IFN)-␥ secreted as a measure for allogeneic T cell stimulatory capacity. Figure 1A demonstrates that mDC have a significantly higher ability to induce IFN-␥ secretion by allogeneic PBL as compared to iDC. Next, the cytokine expression profile of iDC and mDC was determined using a multiplex fluorescent bead immunoassay (Fig. 1B) . For this, cultured DC populations were harvested, washed and stimulated with soluble CD40 ligand (CD40L) for 24 hrs. IL-6, tumour necrosis factor (TNF)-␣ and IL-12 secretion was significantly increased in supernatant of mDC as compared to that of iDC.
Autologous T cell stimulatory capacity of monocyte-derived immature dendritic cells
In order to determine the capacity of iDC to stimulate autologous antigen-specific CD8 + T cells, we co-cultured PBL for 7 days with a MHC class I-restricted cytomegalovirus (CMV) pp65 peptide or influenza M1 peptide with or without autologous iDC or mDC at a 10:1 ratio. Next, cultured PBL were analyzed for the presence and activation of antigen-specific CD8 + T cells by CMV pp65 peptide-specific or influenza M1 peptide-specific T cell tetramer staining and by the level of antigen-specific IFN-␥ secretion. Following restimulation of cultured PBL with CMV pp65 peptide, a significantly lower amount of IFN-␥ was produced by PBL co-cultured with iDC as compared to cultures without iDC ( Fig. 2A) . In addition,
Figures 2B and 2C demonstrate a significantly lower number of influenza M1 (n = 7) peptide-specific CD8 + T cells in T cell cultures after co-culture of PBL with iDC as compared to cultures without iDC. Similar results were obtained when PBL were cultured with CMV pp65 peptide with or without iDC (n = 2, data not shown).
Monocyte-derived immature and mature dendritic cells increase the number of TGF-␤ and IL-10 double-positive CD4 + T cells during co-culture with autologous lymphocytes
In order to understand the low level of autologous T cell activation after co-culture with iDC, we analyzed autologous DC/T cell co-cultures for suppressive T cell populations. For this, PBL were stimulated with CMV pp65 peptide with or without autologous iDC or mDC at a 10:1 ratio. After 6 days of co-culture, cultured cells were characterized by multiparametric flow cytometry in order to determine expression of intracellular immunosuppressive cytokines (Table 1 and Fig. 3) . The results show a significant increase of TGF-␤ and IL-10 double-positive CD4 + T cells in T cell cultures after co-culture with both autologous iDC and mDC. Further analysis confirmed that the majority of TGF-␤-and IL-10-expressing cells are positive for both cytokines (> 70% within the TGF-␤-and/or IL-10-producing cells) and these cells are negative for CD25, CD69, intracellular CTLA-4 and FOXP3 (data not shown), compatible with the phenotype described for adaptive regulatory T cells.
Soluble factors in iDC/T cell co-culture supernatant suppress IFN-␥ production by autologous T cells following antigenic stimulation
The results described above suggest that the low level of autologous T cell activation after co-culture with iDC might be due to the activation of TGF-␤/IL-10-producing T cells by iDC. In order to test this hypothesis, we analyzed iDC/T cell co-culture supernatant samples for the presence of immunosuppressive cytokines. For this, PBL were stimulated with CMV pp65 peptide with or without iDC. After 7 days of coculture, analysis of culture supernatant samples performed with a TGF-␤ ELISA revealed a significantly higher amount of TGF-␤ in the supernatant of the iDC/T cell co-cultures as compared to the T cell cultures stimulated with peptide alone (Fig. 4A ). In contrast, no IL-10 could be detected by ELISA (data not shown). In order to demonstrate that secreted factors (e.g. TGF-␤ and/or IL-10) suppress T cell activation, the following experiments were done. First, when antigenic restimulation of CMV pp65 peptide-stimulated PBL was done in the presence of day 7 iDC/T cell co-culture supernatant, the IFN-␥ response observed was significantly inhibited (Fig. 4B) . Second, when PBL were co-cultured with iDC in the presence of CMV pp65 peptide and with an anti-TGF-␤ and/or anti-IL-10 neutralizing antibody, the level of autologous T cell activation after co-culture with iDC increased. Table 2 demonstrates a significant increase of CMV pp65 peptide-specific IFN-␥ production by PBL stimulated with iDC upon addition of anti-TGF-␤ and anti-IL-10 neutralizing antibodies during initial iDC/T cell co-culture. Moreover, both neutralizing antibodies seem to be working cooperatively: there is only significant increase in antigenspecific IFN-␥ secretion when both antibodies are used together. This strongly suggests that both TGF-␤ and IL-10 are needed to mediate the immunosuppressive effect induced by Treg conditioned by iDC.
CD4 + T cells conditioned by iDC, but not by mDC, inhibit efficient activation of IFN-␥-producing antigen-specific T cells
As demonstrated above, the low level of autologous T cell stimulation observed using iDC is mediated, at least for a major part, by the induction of TGF-␤ + /IL10 + suppressive T cells (Table 2 ). To investigate this hypothesis, we designed the following experimental setup (Fig. 5 ). Purified CD4 + T cells were co-cultured for 48 hrs with iDC or mDC in the absence of antigen. These conditioned CD4 + T cells were then separated from stimulator DC populations by flow cytometric cell sorting and added at a 1:10 ratio to PBL cultures primed for 2 days with CMV pp65 peptide. Next, following 7 days of co-culture, cultured PBL were restimulated with CMV pp65 peptide in order to determine the level of antigen-specific IFN-␥ secretion. Figure 5B demonstrates a significant decrease of the antigen-specific IFN-␥ immune response when CD4 + T cells conditioned by iDC, but not control CD4 + T cells, were added to PBL stimulated with peptide alone. Interestingly, when CD4 + T cells conditioned by mDC were added to PBL stimulated with CMV pp65 peptide, a significant increase of the antigen-specific IFN-␥ immune response was observed as compared to PBL stimulated with peptide alone.
Discussion
In this study, we demonstrate that both immature and mature DC actively induce TGF-␤/IL-10 double-posi- [22, 23] . However, and in contrast to these studies, in our hands, DC maturation performed with TLR ligation seems to impair the inhibitory function of suppressor T cells conditioned by mature DC (mDC). The reason for this difference is not certain at present, but could lie in the difference of TLR ligands used [the TLR3 ligand poly I:C in this study versus the TLR2/4 ligand lipopolysaccharide (LPS) in the studies mentioned above] and in the assay used [autologous antigen-primed DC/T cell co-cultures in this study versus allogeneic mixed leukocyte reactions in the studies mentioned above]. Currently, this subject is under intensive investigation in our laboratory. Our results confirm that iDC are capable of maintaining peripheral tolerance by suppressing allogeneic and autologous T cell responses both at the level of IFN-␥ secretion by antigen-specific T cells and by reducing expansion of antigen-specific T cells. In this study, we also demonstrated that immature DC do not secrete significant amounts of IL-6 and IL-12 as compared to mature DC. It has been shown that both cytokines can restore proliferation and cytokine expression by effector T cells in the presence of regulatory T cells [24] [25] [26] . This feature of mDC is likely to play a role in the efficient T cell activation observed and in the apparent refractoriness to regulatory T cells. In an attempt to reverse the tolerogenic properties of iDC, we added IL-6 and/or IL-12 during T cell activation experiments with iDC. However, in our hands, induction of T cell immunity by iDC was not improved (data not shown). This is consistent with the observations of Medzhitov et al. [24] , who showed that IL-6 is an important but not sufficient factor to reverse suppression by Treg, emphasizing the possible role of other, yet unidentified, factors.
Based on these results, we conclude that DC have a complementary role in inducing both regulatory T cells and effector T cells, where the final result of antigen-specific T cell activation will depend on the activation state of the DC. Our results warrant further investigation into the interplay of regulatory T cell subsets and the mechanisms involved in this inhibition of antigen-specific T cell activation.
